BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Avian flu virus
,
Prozac
,
rs2300478
,
EGFR
,
Metabolism of xenobiotics
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
vismodegib
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Real-world experience with vismodegib on advanced and multiple BCCs: data from the RELIVIS study.
Complete response of a large basosquamous carcinoma following treatment with cemiplimab and vismodeg…
Structure-based discovery of potent USP28 inhibitors derived from Vismodegib.
Review of Targeted Therapy, Vismodegib, for the Treatment of Periocular Basal Cell Carcinoma.
Treatment of basal cell carcinoma with vismodegib: future or present?
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Vismodegib for Treatment of Basal Cell Carcinoma
Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1
Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes
Vismodegib in Basal Cell Carcinomas (BCC) Chemoprevention
Evaluation of Food Effect on Pharmacokinetics of Vismodegib
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ